End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.91 CNY | +0.38% | -2.10% | -11.48% |
Apr. 08 | Shenzhen Xintai Pharmaceutical's Drug to Treat Chronic Heart Failure Set for Clinical Trials | MT |
Mar. 26 | Salubris Pharma's Profit, Revenue Slip in 2023 | MT |
Sales 2024 * | 3.92B 542M | Sales 2025 * | 4.74B 655M | Capitalization | 31.55B 4.36B |
---|---|---|---|---|---|
Net income 2024 * | 687M 94.92M | Net income 2025 * | 839M 116M | EV / Sales 2024 * | 7.23 x |
Net cash position 2024 * | 3.2B 442M | Net cash position 2025 * | 3.18B 439M | EV / Sales 2025 * | 5.99 x |
P/E ratio 2024 * |
48.5
x | P/E ratio 2025 * |
39.1
x | Employees | 3,517 |
Yield 2024 * |
1.83% | Yield 2025 * |
1.5% | Free-Float | 38.31% |
1 day | +0.38% | ||
1 week | -2.10% | ||
Current month | -0.69% | ||
1 month | -1.47% | ||
3 months | -4.68% | ||
6 months | -3.63% | ||
Current year | -11.48% |
Managers | Title | Age | Since |
---|---|---|---|
Jie Yan
CEO | Chief Executive Officer | 51 | 05-12-31 |
Ai Zhen Li
CHM | Chairman | 54 | 04-02-29 |
Yun Kong
DFI | Director of Finance/CFO | 51 | 21-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cheng Hai Ye
BRD | Director/Board Member | 80 | 98-11-02 |
Sing Ye
CHM | Chairman | 49 | 04-06-30 |
Jian Feng Yang
BRD | Director/Board Member | 48 | 05-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.63% | 2 M€ | -20.08% | - | |
0.46% | 2 M€ | -14.14% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-16 | 28.91 | +0.38% | 3 185 464 |
24-04-16 | 28.8 | -2.04% | 4,083,569 |
24-04-15 | 29.4 | +1.59% | 4,003,109 |
24-04-12 | 28.94 | +0.42% | 2,301,190 |
24-04-11 | 28.82 | -1.27% | 2,292,125 |
End-of-day quote Shenzhen S.E., April 16, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.48% | 4.34B | |
+22.08% | 44.09B | |
+18.38% | 22.25B | |
+10.34% | 13.27B | |
+3.70% | 13.15B | |
+37.09% | 11.36B | |
-7.53% | 7.16B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+9.79% | 5.22B |
- Stock Market
- Equities
- 002294 Stock